Cargando…

Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets

Inflammatory bowel disease (IBD) is a chronic, recurrent inflammatory disease of the gastrointestinal tract. In addition to digestive symptoms, patients with IBD may also develop extra-intestinal manifestations (EIMs), the etiology of which remains undefined. The gut microbiota has been reported to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tie, Yizhe, Huang, Yongle, Chen, Rirong, Li, Li, Chen, Minhu, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572083/ https://www.ncbi.nlm.nih.gov/pubmed/37822139 http://dx.doi.org/10.1080/19490976.2023.2265028

Ejemplares similares

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials
por: Chen, Rirong, et al.
Publicado: (2023)

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
por: Chen, Rirong, et al.
Publicado: (2023)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Extra-Intestinal Manifestations of Inflammatory Bowel Disease
por: Sange, Aliya H, et al.
Publicado: (2021)

Is hypertension an extra‐intestinal manifestation of inflammatory bowel disease?
por: Burisch, Johan
Publicado: (2023)

Lung injury as an extra-intestinal manifestation of inflammatory bowel disease
por: Park, Kyung Sik
Publicado: (2016)

Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs
por: Zhan, Shukai, et al.
Publicado: (2021)

Is Multiple Sclerosis an Extra-Intestinal Manifestation of Inflammatory Bowel Disease? Food for Thought
por: Dziadkowiec, Karolina N, et al.
Publicado: (2020)

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians
por: Sinagra, Emanuele, et al.
Publicado: (2020)

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022)

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Li, Jing-Xing, et al.
Publicado: (2022)

Current insights in to the pathophysiology of Irritable Bowel Syndrome
por: Karantanos, Theodoros, et al.
Publicado: (2010)

The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study
por: Ferretti, Francesca, et al.
Publicado: (2022)

Extra-Intestinal Manifestations of Familial Adenomatous Polyposis
por: Groen, Emma J., et al.
Publicado: (2008)

Extra-Intestinal Manifestation of Celiac Disease in Children
por: Jericho, Hilary, et al.
Publicado: (2018)

The Spectrum of Extra-intestinal Manifestation of Crohn's Disease
por: Jumani, Laraib, et al.
Publicado: (2020)

Vulvar Crohn's disease as extra intestinal manifestation
por: Mangoub, Fatima El, et al.
Publicado: (2020)

The emerging role of ferroptosis in intestinal disease
por: Xu, Shu, et al.
Publicado: (2021)

The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review
por: Shrestha, Bijay, et al.
Publicado: (2022)

Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
por: Chen, Minjia, et al.
Publicado: (2022)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

The roles of the gut microbiota–miRNA interaction in the host pathophysiology
por: Li, Meihong, et al.
Publicado: (2020)

Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions
por: Tam, Rachel Y., et al.
Publicado: (2022)

Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations
por: He, Ronghua, et al.
Publicado: (2023)

Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease
por: Wang, Huiling, et al.
Publicado: (2016)

Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes
por: Jansen, Fenna M, et al.
Publicado: (2020)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease
por: Wang, Shu-Ling, et al.
Publicado: (2019)

Dietary Patterns and Gut Microbiota Changes in Inflammatory Bowel Disease: Current Insights and Future Challenges
por: Yan, Jing, et al.
Publicado: (2022)

Role of gut microbiota in type 2 diabetes pathophysiology
por: Gurung, Manoj, et al.
Publicado: (2020)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lcrkimr3d93a29m6juigci5g13